150 related articles for article (PubMed ID: 32154662)
1. Expression profiles of miRNAs in giant cell tumor of bone showed miR-187-5p and miR-1323 can regulate biological functions through inhibiting FRS2.
Jin Y; Zhang J; Zhu H; Fan G; Zhou G
Cancer Med; 2020 May; 9(9):3163-3173. PubMed ID: 32154662
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA expression profiles in metastatic and non-metastatic giant cell tumor of bone.
Mosakhani N; Pazzaglia L; Benassi MS; Borze I; Quattrini I; Picci P; Knuutila S
Histol Histopathol; 2013 May; 28(5):671-8. PubMed ID: 23172052
[TBL] [Abstract][Full Text] [Related]
3. Norcantharidin modulates the miR-30a/Metadherin/AKT signaling axis to suppress proliferation and metastasis of stromal tumor cells in giant cell tumor of bone.
Chen F; Wang S; Wei Y; Wu J; Huang G; Chen J; Shi J; Xia J
Biomed Pharmacother; 2018 Jul; 103():1092-1100. PubMed ID: 29710674
[TBL] [Abstract][Full Text] [Related]
4. MiR-140-5p and miR-92a-3p suppress the cell proliferation, migration and invasion and promoted apoptosis in Wilms' tumor by targeting FRS2.
Li JL; Luo P
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):97-108. PubMed ID: 31957822
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA XIST promotes osteosarcoma progression by targeting YAP via miR-195-5p.
Yang C; Wu K; Wang S; Wei G
J Cell Biochem; 2018 Jul; 119(7):5646-5656. PubMed ID: 29384226
[TBL] [Abstract][Full Text] [Related]
6. Restoration of miR-127-3p and miR-376a-3p counteracts the neoplastic phenotype of giant cell tumor of bone derived stromal cells by targeting COA1, GLE1 and PDIA6.
Fellenberg J; Sähr H; Kunz P; Zhao Z; Liu L; Tichy D; Herr I
Cancer Lett; 2016 Feb; 371(1):134-41. PubMed ID: 26655997
[TBL] [Abstract][Full Text] [Related]
7. Anti-tumor Effects of Cyclolinopeptide on Giant-cell Tumor of the Bone.
Taniguchi Y; Yamamoto N; Hayashi K; Takeuchi A; Miwa S; Igarashi K; Higuchi T; Abe K; Yonezawa H; Araki Y; Morinaga S; Kamei J; Nugroho AE; Kaneda T; Morita H; Tsuchiya H
Anticancer Res; 2019 Nov; 39(11):6145-6153. PubMed ID: 31704842
[TBL] [Abstract][Full Text] [Related]
8. FRS2 regulated by miR-429 and miR-206 promotes angiogenesis in osteosarcoma.
Zhu Y; Liu Z; Cao L; Fan G; Ji R; Zhang L; Daji S; Zhu H; Wang Y; Zhou G
Gene; 2024 Mar; 898():148118. PubMed ID: 38159618
[TBL] [Abstract][Full Text] [Related]
9. MiR-30a inhibits osteolysis by targeting RunX2 in giant cell tumor of bone.
Huang Q; Jiang Z; Meng T; Yin H; Wang J; Wan W; Cheng M; Yan W; Liu T; Song D; Chen H; Wu Z; Xu W; Li Z; Zhou W; Xiao J
Biochem Biophys Res Commun; 2014 Oct; 453(1):160-5. PubMed ID: 25264196
[TBL] [Abstract][Full Text] [Related]
10. MiR-127 and miR-376a act as tumor suppressors by in vivo targeting of COA1 and PDIA6 in giant cell tumor of bone.
Herr I; Sähr H; Zhao Z; Yin L; Omlor G; Lehner B; Fellenberg J
Cancer Lett; 2017 Nov; 409():49-55. PubMed ID: 28866093
[TBL] [Abstract][Full Text] [Related]
11. Prognostic impact of reduced connexin43 expression and gap junction coupling of neoplastic stromal cells in giant cell tumor of bone.
Balla P; Maros ME; Barna G; Antal I; Papp G; Sapi Z; Athanasou NA; Benassi MS; Picci P; Krenacs T
PLoS One; 2015; 10(5):e0125316. PubMed ID: 25933380
[TBL] [Abstract][Full Text] [Related]
12. Nm23-H1 inhibits lung cancer bone-specific metastasis by upregulating miR-660-5p targeted SMARCA5.
Ai C; Ma G; Deng Y; Zheng Q; Gen Y; Li W; Li Y; Zu L; Zhou Q
Thorac Cancer; 2020 Mar; 11(3):640-650. PubMed ID: 32022430
[TBL] [Abstract][Full Text] [Related]
13. miR-1285-3p is a potential prognostic marker in human osteosarcoma and functions as a tumor suppressor by targeting YAP1.
Hu XH; Dai J; Shang HL; Zhao ZX; Hao YD
Cancer Biomark; 2019; 25(1):1-10. PubMed ID: 31006663
[TBL] [Abstract][Full Text] [Related]
14. MiR-199b-5p promotes malignant progression of osteosarcoma by regulating HER2.
Chen Z; Zhao G; Zhang Y; Ma Y; Ding Y; Xu N
J BUON; 2018; 23(6):1816-1824. PubMed ID: 30610808
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-1296-5p suppresses the proliferation, migration, and invasion of human osteosarcoma cells by targeting NOTCH2.
Wang L; Hu K; Chao Y; Wang X
J Cell Biochem; 2020 Feb; 121(2):2038-2046. PubMed ID: 31633240
[TBL] [Abstract][Full Text] [Related]
16. MiR-155-5p exerts tumor-suppressing functions in Wilms tumor by targeting IGF2 via the PI3K signaling pathway.
Luo X; Dong J; He X; Shen L; Long C; Liu F; Liu X; Lin T; He D; Wei G
Biomed Pharmacother; 2020 May; 125():109880. PubMed ID: 32004974
[TBL] [Abstract][Full Text] [Related]
17. LncRNA MEG3 negatively modified osteosarcoma development through regulation of miR-361-5p and FoxM1.
Shen B; Zhou N; Hu T; Zhao W; Wu D; Wang S
J Cell Physiol; 2019 Aug; 234(8):13464-13480. PubMed ID: 30624782
[TBL] [Abstract][Full Text] [Related]
18. The role of the tumor suppressor RUNX3 in giant cell tumor of the bone.
Han YX; Liang DY
Int J Oncol; 2012 Mar; 40(3):673-8. PubMed ID: 22076387
[TBL] [Abstract][Full Text] [Related]
19. miR-200c-3p Suppresses the Proliferative, Migratory, and Invasive Capacities of Nephroblastoma Cells via Targeting FRS2.
Li T; Zhao P; Li Z; Wang CC; Wang YL; Gu Q
Biopreserv Biobank; 2019 Oct; 17(5):444-451. PubMed ID: 31194576
[No Abstract] [Full Text] [Related]
20. miR-5195-3p Suppresses Cell Proliferation and Induces Apoptosis by Directly Targeting NEDD9 in Osteosarcoma.
Wang L; Shi G; Zhu D; Jin Y; Yang X
Cancer Biother Radiopharm; 2019 Aug; 34(6):405-412. PubMed ID: 31411930
[No Abstract] [Full Text] [Related]
[Next] [New Search]
